Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
CytoDyn Inc (CYDY) Message Board
Search
Search Type
Board
Post
Member
New data from Revolutions Bio single arm trial.
Message Board
Public Reply
|
Private Reply
|
Keep
|
Replies
(1)
Post New Msg
Edit Msg
(
) |
Previous
|
Next
Post#
of 148110
(Total Views: 588)
Posted On: 07/15/2024 2:43:34 PM
Posted By:
ohm20
Re:
Nt2innvovate
#145142
Quote:
New data from Revolutions Bio single arm trial.
Their drug is a RAS/RAS mutant inhibitor. Leronlimab would downregulate RAS/RAS mutants via downregulation of the GTP>SRC>GRB2 pathway.
(6)
(0)
CytoDyn Inc (CYDY) Stock Research Links
CYDY Message Board
Company Profile
Time & Sales
Recent News
Filings
Financials
Buy Rating
Newer
Older
Scroll down for more posts ▼
